Skip to main content
. 2017 Sep 5;11(9):e0005781. doi: 10.1371/journal.pntd.0005781

Fig 5. Bar chart showing dose regimens used in visceral leishmaniasis clinical studies.

Fig 5

Bars show the number of patients treated with the drug in visceral leishmaniasis clinical studies. Bars are colored according to the dose regimen.